Sumitomo Pharma Co (FRA:DPM) Ending Cash Position : €178 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Sumitomo Pharma Co Ending Cash Position?

Sumitomo Pharma Co's Ending Cash Position for the quarter that ended in Mar. 2024 was €178 Mil.

Sumitomo Pharma Co's quarterly Ending Cash Position declined from Sep. 2023 (€383 Mil) to Dec. 2023 (€232 Mil) and declined from Dec. 2023 (€232 Mil) to Mar. 2024 (€178 Mil).

Sumitomo Pharma Co's annual Ending Cash Position declined from Mar. 2022 (€1,554 Mil) to Mar. 2023 (€1,003 Mil) and declined from Mar. 2023 (€1,003 Mil) to Mar. 2024 (€178 Mil).

Sumitomo Pharma Co Ending Cash Position Historical Data

The historical data trend for Sumitomo Pharma Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Ending Cash Position Chart

Sumitomo Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

854.91

1,496.85

1,554.34

1,002.58

178.37

Sumitomo Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,002.58	616.88	382.78	232.19	178.37

Sumitomo Pharma Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sumitomo Pharma Co's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	888.035	+	-709.664
	=	178

Sumitomo Pharma Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	223.875	+	-45.504
	=	178

Sumitomo Pharma Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sumitomo Pharma Co (FRA:DPM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (FRA:DPM) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

DNPUF:USA 4506:Japan DPM:Germany

Address

6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.sumitomo-pharma.com

Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.